Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
Martin H. Voss, Arif Hussain, Nicholas J. Vogelzang, et al.
Annals of Oncology (2017) Vol. 28, Iss. 11, pp. 2754-2760
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Smart cancer nanomedicine
Roy van der Meel, Einar Sulheim, Yang Shi, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 11, pp. 1007-1017
Open Access | Times Cited: 1028
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
Shi Su, Peter M. Kang
Nanomaterials (2020) Vol. 10, Iss. 4, pp. 656-656
Open Access | Times Cited: 239
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
Fengzhi Li, Tao Jiang, Qingyong Li, et al.
PubMed (2017) Vol. 7, Iss. 12, pp. 2350-2394
Closed Access | Times Cited: 205
Recent developments in topoisomerase-targeted cancer chemotherapy
Kirk E. Hevener, Tatsiana A. Verstak, Katie E. Lutat, et al.
Acta Pharmaceutica Sinica B (2018) Vol. 8, Iss. 6, pp. 844-861
Open Access | Times Cited: 204
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
W. Kimryn Rathmell, R. Bryan Rumble, Peter J. Van Veldhuizen, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 25, pp. 2957-2995
Open Access | Times Cited: 191
Carrier-free nanomedicines for cancer treatment
Li‐Han Liu, Xian‐Zheng Zhang
Progress in Materials Science (2022) Vol. 125, pp. 100919-100919
Closed Access | Times Cited: 94
Stimulus-responsive self-assembled prodrugs in cancer therapy
Xiao Dong, Rajeev Kungur Brahma, Chao Fang, et al.
Chemical Science (2022) Vol. 13, Iss. 15, pp. 4239-4269
Open Access | Times Cited: 84
Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review
Pingchuan Ma, Guanru Wang, Ke Men, et al.
Nano TransMed (2024) Vol. 3, pp. 100036-100036
Open Access | Times Cited: 20
Integrating Stimuli-Responsive Properties in Host-Guest Supramolecular Drug Delivery Systems
Adam S. Braegelman, Matthew J. Webber
Theranostics (2019) Vol. 9, Iss. 11, pp. 3017-3040
Open Access | Times Cited: 118
mRNA-to-protein translation in hypoxia
Nancy T. Chee, Ines Lohse, Shaun P. Brothers
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 93
Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments
Paz de la Torre, María Jesús Pérez-Lorenzo, Álvaro Alcázar-Garrido, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 715-715
Open Access | Times Cited: 80
An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor
Yukari Shirai, Christalle C. T. Chow, Gouki Kambe, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2813-2813
Open Access | Times Cited: 57
Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives
Mangala Hegde, Nikunj Naliyadhara, Jyothsna Unnikrishnan, et al.
Cancer Letters (2023) Vol. 556, pp. 216066-216066
Closed Access | Times Cited: 38
pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery
Henglai Sun, Xinyu Li, Qian Liu, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 6, pp. 672-706
Closed Access | Times Cited: 9
Hypoxic Microenvironment and Metastatic Bone Disease
Toru Hiraga
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3523-3523
Open Access | Times Cited: 65
Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials
Anne Nguyen, Roland Böttger, Shyh‐Dar Li
Biomaterials (2021) Vol. 275, pp. 120955-120955
Closed Access | Times Cited: 46
Nanomedicine from amphiphilized prodrugs: Concept and clinical translation
Jiajia Xiang, Xin Liu, Guiping Yuan, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114027-114027
Closed Access | Times Cited: 46
Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment
Asmita Yadav, Sakshi Singh, Harmik Sohi, et al.
AAPS PharmSciTech (2021) Vol. 23, Iss. 1
Closed Access | Times Cited: 45
The design and discovery of topoisomerase I inhibitors as anticancer therapies
Endika Martín‐Encinas, Asier Selas, Francisco Palácios, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 6, pp. 581-601
Closed Access | Times Cited: 33
Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review
Anandakrishnan Karthic, Arpita Roy, Jaya Lakkakula, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 32
Targeting hypoxia in solid and haematological malignancies
Bill Harris, Sana Saleem, Natalie Cook, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 32
Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine
Alessandro Parodi, Ekaterina Kolesova, Maya V. Voronina, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13368-13368
Open Access | Times Cited: 29
Camptothecin-based prodrug nanomedicines for cancer therapy
Renshuai Zhang, Jing Yu, Zhu Guo, et al.
Nanoscale (2023) Vol. 15, Iss. 44, pp. 17658-17697
Closed Access | Times Cited: 19
The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions
Tianqi Zhang, Qianyu Lv, Weilin Jin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189137-189137
Closed Access | Times Cited: 8
Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression
Mohammad Habeeb, Shivani Arsey, Huay Woon You, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105983-105983
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top